Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - hydroxychloroquini sulfas - compresse rivestite con film - hydroxychloroquini sulfas 200 mg, excipiens pro compresso obducto. - la malaria, il lupus erythematodes, chronische poliartrite - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - hydroxychloroquini sulfas - lactab - hydroxychloroquini sulfas e 200 mg, maydis per amylum, calcio hydrogenophosphas dihydricus, silice colloidalis anhydrica, polysorbatum 80, talco, magnesio stearas, Überzug: hypromellosum, talco, e 171, macrogolum 6000, per compresso haze. - la malaria, il lupus erythematodes, chronische poliartrite - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - hydroxychloroquini sulfas - compresse rivestite con film - hydroxychloroquini sulfas 200.00 mg, calcii hydrogenophosphas dihydricus, povidonum, natrii hydrogenocarbonas corresp. natrium 0.27 mg, magnesii stearas, Überzug: hydroxypropylcellulosum, hypromellosum, e 171, macrogolum 400, macrogolum 8000, pro compresso obducto. - la malaria, il lupus erythematodes, chronische poliartrite - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

Unione Europea - italiano - EMA (European Medicines Agency)

cis bio international - yttrium (90y) chloride - imaging dei radionuclidi - radiofarmaci diagnostici - da utilizzare solo per la marcatura radioattiva di molecole carrier espressamente sviluppate e autorizzate per la radiomarcatura con questo radionuclide. radiopharmaceutical precursor - not intended for direct application to patients.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

b.e.imaging.ag - thallosi(201-tl) chloridum per kalibrierungszeitpunkt - soluzione iniettabile - thallosi(201-tl) chloridum zum kalibrierungszeitpunkt 37 mbq, natrii chloridum, natrii hydroxidum, acidum hydrochloridum ad ph, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.5 mg. - szintigraphische indagine della myokarddurchblutung - radiopharmazeutika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sintetica sa - kalii chloridum - fiale supplementari per perfusioni - kalii chloridum 150 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. chloridum 2 mmol, kalium 2 mmol. - terapia potassica - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

amino ag, fabrikation pharmazeutischer und chemischer produkte - natrii chloridum - soluzione iniettabile - natrii chloridum 9 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 154 mmol, chloridum 154 mmol/l. - trägerlösung - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sintetica sa - natrii chloridum - concentrato di perfusione - natrii chloridum 100 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.7 mmol, chloridum 1.7 mmol. - apporto di chloruro di sodio - synthetika